Expert Video - What is most important for me to ask my doctor about my AML?
Dr. Sandra Kurtin, expert on acute myeloid leukemia or AML, explains that the outlook and treatment options for someone with AML are different depending on the type of disease, any genetic changes that are present, and other factors. Knowing your AML subtype, including the results ofchromosome and genetic tests, is very important in knowing your outlook and planning for treatment.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.